HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seungwon Kim Selected Research

Seungwon Kim Research Topics

Disease

45Neoplasms (Cancer)
06/2022 - 12/2004
26Squamous Cell Carcinoma of Head and Neck
06/2022 - 12/2005
15Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 05/2008
10Anaplastic Thyroid Carcinoma
01/2019 - 12/2004
6Neoplasm Metastasis (Metastasis)
06/2022 - 12/2005
4Thyroid Neoplasms (Thyroid Cancer)
10/2012 - 12/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2005
2Deglutition Disorders (Dysphagia)
08/2017 - 01/2013
2Hemorrhage
01/2017 - 01/2016
2Fistula
12/2014 - 04/2012
2Carcinogenesis
07/2013 - 08/2012
1Human Influenza (Influenza)
03/2022
1Thrombophilia
03/2022
1Stroke (Strokes)
03/2022
1Dermatitis
01/2022
1Inflammation (Inflammations)
12/2021
1Malaria
01/2021
1Facial Pain (Myofacial Pain)
01/2018
1Margins of Excision
01/2018
1Extranodal Extension
01/2018
1Paresis (Hemiparesis)
01/2018
1Paresthesia (Dysesthesia)
01/2018
1Sleepiness
11/2017
1Obstructive Sleep Apnea
11/2017
1Pain (Aches)
08/2017
1Postoperative Hemorrhage
01/2017
1Parotid Neoplasms
01/2015
1Hypoxia (Hypoxemia)
01/2014
1Lymphatic Metastasis
09/2013

Drug/Important Bio-Agent (IBA)

10Cetuximab (Erbitux)FDA Link
01/2022 - 01/2006
9ErbB Receptors (EGF Receptor)IBA
01/2019 - 12/2004
7Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2013
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 03/2005
6Monoclonal AntibodiesIBA
06/2020 - 05/2008
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2012 - 12/2005
5Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2007 - 04/2005
4Paclitaxel (Taxol)FDA LinkGeneric
08/2007 - 04/2005
4Epidermal Growth Factor (EGF)IBA
11/2006 - 12/2004
4Irinotecan (Camptosar)FDA LinkGeneric
08/2006 - 12/2005
3LigandsIBA
12/2021 - 08/2006
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2014 - 08/2012
3Bevacizumab (Avastin)FDA Link
12/2013 - 04/2007
3Tyrosine Kinase InhibitorsIBA
08/2007 - 12/2005
3AEE 788 (AEE788)IBA
11/2006 - 04/2005
2CarcinogensIBA
01/2020 - 07/2018
2Gefitinib (Iressa)FDA Link
01/2019 - 12/2004
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 06/2014
2OligonucleotidesIBA
01/2014 - 08/2012
2Angiogenesis InhibitorsIBA
01/2014 - 01/2014
2Interleukin-8 (Interleukin 8)IBA
08/2013 - 03/2005
2Proteins (Proteins, Gene)FDA Link
08/2012 - 08/2005
2Cisplatin (Platino)FDA LinkGeneric
12/2010 - 11/2006
2Phosphotransferases (Kinase)IBA
06/2007 - 11/2006
2vatalanib (PTK787)IBA
05/2006 - 12/2005
1VaccinesIBA
03/2022
1IpilimumabIBA
01/2022
1SteroidsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
12/2021
1Neuropilin-1IBA
12/2021
1Semaphorins (Semaphorin)IBA
01/2021
1InsecticidesIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2020
1ficlatuzumabIBA
06/2020
1Environmental CarcinogensIBA
01/2020
1Tumor Biomarkers (Tumor Markers)IBA
10/2019
1Neuregulin-1 (Neuregulin 1)IBA
10/2019
1AlpelisibIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1Antisense DNAIBA
10/2018
1VTX-2337IBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1Dasatinib (BMS 354825)FDA Link
01/2017
1src-Family KinasesIBA
01/2017
1AnticoagulantsIBA
01/2017
1Sulindac (Copal)FDA LinkGeneric
06/2014
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2013
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2013

Therapy/Procedure

18Therapeutics
06/2022 - 12/2004
12Radiotherapy
06/2022 - 05/2008
5Neck Dissection (Radical Neck Dissection)
03/2022 - 04/2012
3Drug Therapy (Chemotherapy)
01/2017 - 11/2006
2Immunotherapy
06/2022 - 01/2021
2Chemoradiotherapy
01/2018 - 12/2010
2Free Tissue Flaps
01/2017 - 12/2014
2Ligation
01/2017 - 01/2016
2Re-Irradiation
01/2016 - 03/2015
2Laryngectomy
12/2014 - 04/2012
1Thrombectomy
03/2022
1Injections
10/2018
1Anesthesia
01/2018
1Enteral Nutrition (Feeding, Tube)
08/2017
1Perioperative Period
08/2017
1Combined Modality Therapy
01/2017
1Aftercare (After-Treatment)
01/2017
1Tonsillectomy
01/2017
1Adjuvant Chemoradiotherapy
01/2016
1Robotic Surgical Procedures
01/2016
1Glossectomy
12/2015
1Myocutaneous Flap
12/2014